|
|
本帖最后由 douban 于 2016-8-27 12:00 编辑 . J; V1 f7 D0 f- k4 x
- }5 _8 ?" Z2 Q/ I/ a% G$ eDevelopment of Novel Vaccines; n3 Y' a- m! q/ w; U% W
5 s E8 I l+ A
Skills, Knowledge and Translational Technologies4 V# m( J6 {7 ?5 R+ ?3 N
0 J2 n& J" }3 m2 H% z: n7 F z; d
Editors: von Gabain, Alexander, Klade, Christoph (Eds.) $ ^ O. J3 W5 m6 Z
* }/ U" q1 M2 ]( T% [- H
/ }$ p, r0 T6 o' P% s+ a$ R& k, y* n3 n
About this book; E# c9 n* d8 K; Y* @
& ^# {8 h1 P8 o8 i0 I8 q' P“Development of novel vaccines” gives an overview of the tasks in basic research leading to the final product – the vaccine and its applications, belonging to the most complex biologics in the pharmaceutical field. Distinct from most textbooks in the vaccine arena, the current issue focuses on the translational aspect, namely, how research results can be transformed into life-saving medical interventions. Each chapter of the book deals with one important paradigm for the development of novel vaccines, along the value chain towards the final vaccine, and furthermore, with the inevitable tools required for this process. Contributions are prepared by teams of scientists, all of whom are experts in the field, most of them anchored in biomedical organizations devoted to translational culture, thereby lighting the certain topics from different views. This volume is a must read for researchers engaged in vaccine development and who really want to see their research results to become a product.
3 Z5 d% w+ O0 C3 Z
5 T* \ G1 P! T$ W9 t6 C
. N, _! d& t. PTable of contents (11 chapters)
7 D4 i/ n9 K2 K; J" r) J& t& ~* J, B# U6 n7 {
: P! [; q& ^& `+ c+ f/ ^6 d
Skills, Knowledge, and Translational Technologies Leading to Novel Vaccines
3 i; P6 z2 K3 ]+ p- w; z6 u6 p1 Y2 w0 d4 N( l8 k8 {
Alkan, Şefik Ş.
: h( |7 z/ `4 @# K
; r3 \, M" ~: {1 g5 l. fPages 1-26! S0 u( z; P; U. y: l1 i
9 I/ Y, n, {0 G# Y) t" p
Finding Protective Bacterial Antigens! S4 V( \7 u/ ]- h7 T( h/ p9 J
+ L W4 Z9 L, Z: C4 d
Grandi, Guido (et al.)
/ r2 y( s7 D% Z1 f& a D
. ?2 {$ ^& W: |: b" PPages 27-44
- @. R* j+ @% b* `, A8 A" e* p" B
' a7 }# |6 r; d7 Z( ZEnhancing and Tailoring the Immunogenicity of Vaccines with Novel Adjuvants1 f0 u* ?; t7 {
* s6 f) p7 b# h' o! @& hFox, Christopher B. (et al.)
$ a8 Z6 v K$ T4 I1 B L* m3 ^+ [8 P$ U2 l: J3 d
Pages 45-72
- ~4 l8 J( s6 J3 h) r" i' h5 w. ?6 s7 r
5 G" R& J7 E" R
8 @0 a: s4 R) |! E. \Vaccine Delivery: Beyond Needles
8 Y. A9 @- w0 j }# F
" O3 Z6 T( o8 G. n+ |Flyer, David C. (et al.)# L W# @& M+ k/ h. U( F4 F
/ L9 ^4 Q9 T, r( H0 Y1 H9 I( L
Pages 73-86
, L! F2 D1 m& x& D
+ q( C$ S6 }' _$ p" I
& {9 {+ C- a- z' k9 k6 O
3 O+ i% | K. C+ ~Employing Live Microbes for Vaccine Delivery
$ e, L/ [8 B/ J3 v
1 N7 L( R3 J0 [) r8 kLoessner, Holger (et al.)
- ]( m1 T8 r' e2 s4 I1 V# E% e
l) I1 q+ ~7 H d. iPages 87-124
9 F- x4 x# B: m* W. M& w2 p; ~" q, j( e. R ]1 N \) A
- M- C& N$ d7 O. Q
+ H6 K6 Y8 Y6 n; o" v( l
Synthesizing Vaccines with Microbes. y* m+ y# O# X" c! R
/ h# P+ ~$ t9 T& ]+ \0 L6 `Wacker, Michael (et al.)
/ ^4 B, {8 g; R- w% N. I: o
+ b7 V0 e* H5 hPages 125-144
0 Q" y. ^$ h2 |1 s
* p% q/ K+ _" _
; O# G8 Q$ g6 U+ }0 Z" U+ Z# j2 _) S; J9 o4 k( v9 b
Purification and Formulation: Silent but Important Players in Vaccine Development- T9 y1 T. c4 Y+ q. N) v5 I0 C9 p
$ H' S0 x# T( ISchlegl, Robert (et al.)% @: C* F# L9 [; @
; `! c/ e. A+ S* _; D) b( dPages 145-188
2 H' n& L3 T) v: c7 C9 T8 ]
4 f6 q# r5 q( f& T: w7 ^7 F( n M& Z1 s a- g
& s3 R, S( R( W% C/ P: ^Cutting-Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines! C3 f2 l% j4 K7 U
9 k% |) u% C* }: i$ ^; t/ A# [
Arnon, Ruth (et al.)
. Y# `4 q ~( w8 W% H' j% M& W3 P2 X; h/ I7 T/ ^0 U, D6 M
Pages 189-2046 z0 E- ~( {& f$ ^
5 e; J/ b+ K( s) [/ x
* I' q# @5 j- s2 ~6 b( G
1 ~, b# E% f3 @& LCutting Edge Approaches Toward Novel and Cross-Protective Influenza Vaccines
$ i1 R$ O, F' Z+ I4 V, o
" A( [. `$ E! }- c! ?Roose, Kenny (et al.)
( P/ E& C3 {/ v$ [. T* `) F- e' W0 @* L
Pages 205-232) h) c0 [0 H+ F% E$ Q9 @$ |
" w3 @. H" B! f3 J( `$ B. B
' {: S: }1 d, c* Y1 I4 f1 ^# ?* ^
- w( N$ b# g1 F7 ~6 _4 \Examples of Novel Registered Prophylactic Vaccines, HPV, and JEV( {% y2 A; t5 _8 Y
* g/ a& X8 I2 o, NDubischar-Kastner, Katrin (et al.)) L/ v; U8 k: m/ \1 B+ Z+ W
6 V. C7 t& I( VPages 233-2864 f3 E2 o4 v4 w
; p2 x- K1 T1 Z# Y* J ?$ Z* F, u* V2 }0 Z1 w
* ]0 e3 K3 T- BThe Bumpy Road Toward Vaccine Registration: How to Overcome Regulatory Hurdles7 S7 w* S& p! x" r* y
- i' U+ e: N$ e; V2 n1 kPfleiderer, Michael" E( Q/ X7 `4 ?2 O0 W6 a
0 u+ x% }/ m1 ?7 r7 wPages 287-3007 w2 h' v5 D* ~$ K
4 H* j# f. A+ E下载链接：
1 }" P* h. |1 f4 e, D. i7 V7 E( ]& w7 V
|
本帖子中包含更多资源
您需要 登录 才可以下载或查看，没有账号？立即注册
×
评分
-
查看全部评分
|
发表于 2016-8-27 11:57:27
发表于 2016-8-27 12:54:55
